661509-1f19f266-0296-402b-9776-94090d067cfb
Position
President & Chief Executive Officer
Company
Inovio
Location
Plymouth Meeting Pennsylvania UNITED STATES
Bio
J. Joseph Kim, Ph.D., entrepreneur, immunologist, and health policy leader, is co-founder and chief executive officer of Inovio, a biotechnology company leading the world in developing novel immunotherapies -- medicines that attack a broad array of cancers and challenging infectious diseases by training the body’s immune system to identify and fight disease. He previously developed vaccines for Merck & Co. An immunologist by training, Joseph holds an MIT undergraduate degree, a PhD in biochemical engineering from the University of Pennsylvania, and an MBA from The Wharton School. He has published more than 100 scientific papers, holds numerous patents, and sits on editorial boards and scientific review panels. In 2015, Dr. Kim was named Entrepreneur of the Year for Life Sciences by Ernst and Young in the Philadelphia region. He also serves on the board of the International Vaccine Institute and the Council of Korean Americans. The World Economic Forum selected Dr. Kim as a member of its Global Agenda Council and named him a Technology Pioneer as well as one of its Young Global Leaders. He is a frequent guest on CNBC’s Fast Money and other financial programs, where he comments on Inovio’s breakthroughs and the pharmaceutical landscape. MIT’s Technology Review magazine called him "one of the world’s top innovators." Joseph is a Fellow of the inaugural class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network where he is working with a team to develop a vision of tomorrow’s healthcare system.
Interests
None yet.